Use in Pregnancy and Breastfeeding Caution is needed when using semaglutide during pregnancy and breastfeeding
In the overweight/obese group, the sample size was 979 patients
5.2 Acute Pancreatitis Acute pancreatitis, including fatal and non-fatal hemorrhagic or necrotizing pancreatitis, has been observed in patients treated with GLP-1 receptor agonists, including OZEMPIC [see Adverse Reactions (6)]
However, **this is theory, not proven fact in humans for Tirzepatide.** * **Potential Indirect Concerns:** Some resources also raise concerns that the medications side effects on the mother (like nausea, vomiting, diarrhea, decreased appetite leading to significant caloric deficit) could potentially impact hydration, milk supply, or even the nutrient density of breast milk, although this also requires more research
How is the NiceRx microdose tirzepatide program different than other GLP-1 program
Optimizing your semaglutide B12 protocol for maximum results Taking the right dose at the right time is the foundation